Literature DB >> 8369104

Alteration of protein kinase C activity in the postischemic rat brain areas using in vitro [3H]phorbol 12,13-dibutyrate autoradiography.

H Nagasawa1, T Araki, K Kogure.   

Abstract

Chronological changes of protein kinase C (PKC) activity were measured using in vitro [3H]phorbol 12,13-dibutyrate (PDBu) autoradiography to investigate the postischemic alteration of this second messenger system in the rat brain. Transient ischemia was induced by the occlusion of the middle cerebral artery (MCA) for 90 min and such occlusion followed by various recirculation periods of up to 4 weeks. After 90 min of ischemia followed by 3 hours of recirculation, [3H]PDBu binding sites were found to be significantly decreased in the cerebral cortex and lateral segment of the caudate putamen, both supplied by the occluded MCA; thereafter, the binding sites decreased progressively in those ischemic foci. On the contrary, there was no alteration on day 1, but 3 days after ischemic insult, a significant decrease of [3H]PDBu binding sites was first detected in the ipsilateral thalamus and the substantia nigra, which both areas had not been directly affected by the original ischemic insult. This postischemic delayed phenomenon observed in the thalamus and the substantia nigra developed concurrently with 45Ca accumulation, which was detected there in our previous study. These results suggest that alteration of second messenger (PKC) pathways may be involved not only in the ischemic foci, but also in neuronal degeneration of the exo-focal remote areas in relation to the disruption of intracellular calcium homeostasis which plays a key role in the pathogenesis of postischemic neuronal damage and that marked alteration of intracellular signal transduction may precede the neuronal damage in the exo-focal postischemic brain areas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369104     DOI: 10.1007/bf01244870

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  37 in total

1.  Heterogeneous localization of protein kinase C in rat brain: autoradiographic analysis of phorbol ester receptor binding.

Authors:  P F Worley; J M Baraban; S H Snyder
Journal:  J Neurosci       Date:  1986-01       Impact factor: 6.167

2.  Protein kinase C injection into hippocampal pyramidal cells elicits features of long term potentiation.

Authors:  G Y Hu; O Hvalby; S I Walaas; K A Albert; P Skjeflo; P Andersen; P Greengard
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

Review 3.  Turnover of inositol phospholipids and signal transduction.

Authors:  Y Nishizuka
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

Review 4.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

5.  Phorbol esters broaden the action potential in CA1 hippocampal pyramidal cells.

Authors:  J F Storm
Journal:  Neurosci Lett       Date:  1987-03-20       Impact factor: 3.046

Review 6.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

7.  Mapping second messenger systems in the brain: differential localizations of adenylate cyclase and protein kinase C.

Authors:  P F Worley; J M Baraban; E B De Souza; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Exo-focal postischemic neuronal damage in the rat brain: alteration of [3H]forskolin binding using in vitro autoradiography.

Authors:  H Nagasawa; K Kogure
Journal:  Brain Res       Date:  1991-11-01       Impact factor: 3.252

9.  Specific binding of phorbol ester tumor promoters.

Authors:  P E Driedger; P M Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion.

Authors:  H Nagasawa; K Kogure
Journal:  Stroke       Date:  1989-08       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.